ResearcherIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'OrsolaNo recent work listed
Guido Biasco
Matched on ORCID iD 0000-0001-5813-8748; OpenAlex author ID A5067159913. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 2
- Collaborators
- 21
2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 1 paper
Papers 7
- Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. Co-author DOI 10.3892/ijo.2018.4344↗
- The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols for Extraction and PCR Analysis. Co-author DOI 10.1007/978-1-4939-3347-1_10↗
- MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step to… Co-author DOI 10.1186/s13148-015-0162-5↗
- Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array. Last author DOI 10.3892/mmr.2015.4344↗
- Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. Last author DOI 10.1097/mpa.0b013e3182a6486e↗
- Hedgehog signaling: from the cuirass to the heart of pancreatic cancer. Last author DOI 10.1016/j.pan.2012.06.001↗
- Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer: A literature review and report of two cases. Last author DOI 10.3892/ol.2011.253↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mariacristina Di Marco · 5 shared papers, 2011–2018 · strength 0.21
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Paper Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. DOI 10.1097/mpa.0b013e3182a6486e↗
- Paper Hedgehog signaling: from the cuirass to the heart of pancreatic cancer. DOI 10.1016/j.pan.2012.06.001↗
- Marina Macchini · 4 shared papers, 2011–2015 · strength 0.14
- Paper Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. DOI 10.1097/mpa.0b013e3182a6486e↗
- Paper Hedgehog signaling: from the cuirass to the heart of pancreatic cancer. DOI 10.1016/j.pan.2012.06.001↗
- Paper Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by s… DOI 10.3892/mmr.2015.4344↗
- Riccardo Casadei · 3 shared papers, 2011–2018 · strength 0.13
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Paper Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by s… DOI 10.3892/mmr.2015.4344↗
- Paper Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer: A literature review and report of two… DOI 10.3892/ol.2011.253↗
- Ingrid Garajová · 2 shared papers, 2015–2016 · strength 0.12
- Paper The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols f… DOI 10.1007/978-1-4939-3347-1_10↗
- Paper MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similaritie… DOI 10.1186/s13148-015-0162-5↗
- Elisa Giovannetti · 2 shared papers, 2015–2016 · strength 0.12
- Paper The Role of MicroRNAs in Resistance to Current Pancreatic Cancer Treatment: Translational Studies and Basic Protocols f… DOI 10.1007/978-1-4939-3347-1_10↗
- Paper MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similaritie… DOI 10.1186/s13148-015-0162-5↗
- Carla Serra · 2 shared papers, 2015–2018 · strength 0.10
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Paper Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by s… DOI 10.3892/mmr.2015.4344↗
- Elisa Grassi · 2 shared papers, 2015–2018 · strength 0.10
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Paper Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by s… DOI 10.3892/mmr.2015.4344↗
- Claudio Ricci · 2 shared papers, 2015–2018 · strength 0.10
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Paper Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by s… DOI 10.3892/mmr.2015.4344↗
- Francesco Minni · 2 shared papers, 2015–2018 · strength 0.10
- Paper Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, pre… DOI 10.3892/ijo.2018.4344↗
- Paper Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by s… DOI 10.3892/mmr.2015.4344↗
- Tessa Y. S. Le Large · 1 shared paper, 2016 · strength 0.07
- Godefridus J. Peters · 1 shared paper, 2016 · strength 0.07
- Geert Kazemier M · 1 shared paper, 2016 · strength 0.07
- Francesca Comito · 1 shared paper, 2018 · strength 0.06
- Daria Maria Filippini · 1 shared paper, 2018 · strength 0.06
- Giovanni Brandi · 2 shared papers, 2011–2014 · strength 0.06
- Niccola Funel · 1 shared paper, 2015 · strength 0.05
- Adam Enver Frampton · 1 shared paper, 2015 · strength 0.05
- Giorgio Ercolani · 1 shared paper, 2015 · strength 0.04
- Antonio Daniele Pinna · 1 shared paper, 2015 · strength 0.04
- Stefano Fanti · 1 shared paper, 2011 · strength 0.02
- Raffaele Pezzilli · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.